+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 11Years - 18Years
All Genders
Healthy Volunteers
ID05096273

Retraining and Control Therapy ReACT for Pediatric Psychogenic Non-Epileptic Seizures Targeting Sense of Control and Symptom Expectations in Children and Teens

Led by University of Alabama at Birmingham · Updated on 2026-08-26

68

Participants Needed

1

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating Retraining and Control Therapy ReACT, a cognitive behavioral treatment aimed at improving sense of control and reducing catastrophic symptom expectations in children and teenagers aged 11 to 18 diagnosed with pediatric psychogenic non-epileptic seizures PNES. These seizures resemble epileptic seizures but lack a medical cause. The study focuses on understanding these psychological targets to improve therapy outcomes for PNES. Participants will complete twelve weekly ReACT therapy sessions, with the initial visit lasting up to two hours and the following sessions lasting about one hour each. During the study, participants will undergo the cold pressor test CPT twice at baseline, with randomization to a pain relief or pain sensitivity lotion applied during the second test. After finishing the 12 sessions, half of the participants will receive two booster therapy sessions at 3 and 9 months post-treatment. Healthy controls matched by age, gender, race, and family income will have baseline and follow-up visits similar to those with PNES. Throughout the study, participants and their parents will complete questionnaires assessing mood, symptoms, and quality of life. PNES frequency will be tracked using diaries from 30 days before treatment to 12 months after. Assessments include tasks measuring sense of control, pain tolerance, cortisol response, and cognitive tests at baseline, mid-treatment, post-treatment, and long-term follow-ups at 6 and 12 months via secure video calls. Participants will wear Actiwatch devices to monitor sleep and seizure severity during specific periods. Saliva samples will be collected to measure stress hormone responses during CPT visits.

CONDITIONS

Brief Title

Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES

Research Team

A

Aaron Fobian, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here